Milton C. Ault III - 16 Mar 2023 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
10%+ Owner
Signature
/s/ Milton C. Ault, III
Issuer symbol
ALZN
Transactions as of
16 Mar 2023
Net transactions value
+$4,155
Form type
4
Filing time
20 Mar 2023, 16:30:16 UTC
Previous filing
17 Feb 2023
Next filing
07 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $2,006 +4,000 +0.04% $0.5014 11,055,001 16 Mar 2023 By Ault Lending, LLC F1, F2
transaction ALZN Common Stock Purchase $2,149 +5,000 +0.05% $0.4298 11,060,001 17 Mar 2023 By Ault Lending, LLC F2
holding ALZN Common Stock 2,500,000 16 Mar 2023 Direct
holding ALZN Common Stock 365,000 16 Mar 2023 By Ault Alpha LP F3
holding ALZN Common Stock 14,942,984 16 Mar 2023 By Ault Life Sciences, Inc. F4
holding ALZN Common Stock 10,000,000 16 Mar 2023 By Ault Life Sciences Fund, LLC F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.5014. The range of purchase prices on the transaction date was $0.5014 to $0.5015 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
F2 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AA"). Mr. Ault, the Executive Chairman of AA, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F3 Milton C. Ault, III, is the Manager of Ault Alpha GP LLC ("Ault GP") and Ault Capital Management LLC ("AC Management"). Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F5 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.